NCT03366545

Brief Summary

The registry is primarily designed to assess outcome, efficacy and residual safety aspects of CRT based on long-term data from an unselected, real-life clinical set-up. Moreover, the observation of the patient status should help to find possible predictors for HF events and to identify areas of improvement for CRT and for CRT device settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
3,030

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started May 2018

Longer than P75 for all trials

Geographic Reach
19 countries

107 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
May 2018Jun 2026

First Submitted

Initial submission to the registry

November 27, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 8, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

May 14, 2018

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 22, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

7.4 years

First QC Date

November 27, 2017

Last Update Submit

February 10, 2026

Conditions

Keywords

cardiac resynchronization therapyCRTclinical routine

Outcome Measures

Primary Outcomes (11)

  • Number of cardiovascular adverse events

    Number of unplanned hospitalization for cardiovascular cause

    throughout study duration, average of 3.5 years; annual evaluations

  • Number of patient deaths

    Number of all-cause mortality

    throughout study duration, average of 3.5 years; annual evaluations

  • Number of all cause hospitalization

    Number of all cause hospitalization

    throughout study duration, average of 3.5 years; annual evaluations

  • Number of patients with worsening of heart failure events

    Number of unplanned hospitalization for worsening of heart failure

    throughout study duration, average of 3.5 years; annual evaluations

  • Number of patients with cerebrovascular events

    Number of cerebrovascular events requiring hospitalization

    throughout study duration, average of 3.5 years; annual evaluations

  • Number of all adverse device effects

    Number of all adverse device effects

    throughout study duration, average of 3.5 years; annual evaluations

  • Number of all device deficiencies

    Number of all device deficiencies

    throughout study duration, average of 3.5 years; annual evaluations

  • Assessment of patients benefit from CRT

    Documentation of NYHA classification \[I-IV\]

    throughout study duration, average of 3.5 years; annual evaluations

  • Number of patient deaths with cardiovascular cause

    Number of patient deaths with cardiovascular cause

    throughout study duration, average of 3.5 years; annual evaluations

  • Documentation of LVEF

    Left ventricular ejection fraction \[%\]

    throughout study duration, average of 3.5 years; annual evaluations

  • Documentation of LVESV

    Left ventricular end-systolic volume \[ml\]

    throughout study duration, average of 3.5 years; annual evaluations

Interventions

Observation and documentation of routine care for CRT patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Representative population of CRTpatients at clinical sites

You may qualify if:

  • Planned de novo implantation of or upgrade to a CRT system for treatment according to the intended use
  • Patient is able to understand the nature of the registry and has provided written informed consent
  • Patient is willing and able to use the CardioMessenger and accepts the Home Monitoring concept
  • Remote monitoring using the Home Monitoring® platform is planned for the patient

You may not qualify if:

  • Standard contraindication for CRT
  • Already or previously implanted with CRT system
  • Age \< 18 years
  • Participation in another interventional clinical investigation other than the registry-based trials of BIO\|STREAM.HF
  • Pregnant or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (114)

Canberra Heart Rhythm Foundation

Canberra, Australia

Location

The Canberra Hospital

Canberra, Australia

Location

Lyell McEwin Hospital

Elizabeth Vale, Australia

Location

Liverpool Hospital

Liverpool, Australia

Location

Sydney Adventist Hospital

Sydney, Australia

Location

Westmead Hospital

Westmead, 2145, Australia

Location

Westmead Private Hosptial

Westmead, Australia

Location

Kepler Universitätsklinikum

Linz, Austria

Location

Universitätsklinikum St. Pölten

Sankt Pölten, Austria

Location

Medizinische Universität Wien

Vienna, Austria

Location

Imelda Ziekenhuis

Bonheiden, 2820, Belgium

Location

UZ Brussel

Brussels, 1090, Belgium

Location

CHR de la Citadelle - Liège

Liège, Belgium

Location

Nemocnice České Budějovice

České Budějovice, Czechia

Location

Fakultní nemocnice Olomouc

Olomouc, 77900, Czechia

Location

Institute for Clinical and Experimental Medicine (IKEM)

Prague, Czechia

Location

CHU de Brest

Brest, France

Location

Le Centre Hospitalier Universitaire de CAEN

Caen, France

Location

Centre Hospitalier Louis Pasteur

Chartres, France

Location

CH Saint Philibert

Lomme, France

Location

Centre Hospitalier Lorient

Lorient, France

Location

Hôpital privé Clairval

Marseille, 13009, France

Location

Hopital de la Timone (CHU La Timone)

Marseille, France

Location

Hôpital Privé / Institute Jaques Cartier

Massy, France

Location

Clinique les Fontaines

Melun, France

Location

CHU Montpellier

Montpellier, France

Location

Clinique du Millenaire

Montpellier, France

Location

Hôpital privé du Confluent

Nantes, France

Location

Hopital Pitie-Salpetriere

Paris, France

Location

Hôpital Haut Lévêque

Pessac, France

Location

Centre Hospitalier de Périgeux

Périgueux, France

Location

Centre Hospitalier Universitaire de Saint-Étienne

Saint-Etienne, France

Location

Centre Hospitalier Mémorial de Saint-Lô

Saint-Lô, France

Location

Hôpitaux Universitaires de Strasbourg

Strasbourg, France

Location

Centre Hospitalier de Rangueil

Toulouse, France

Location

Clinique Pasteur Toulouse

Toulouse, France

Location

Chru de Tours

Tours, France

Location

CH de Valence

Valence, France

Location

Centre Hospitalier Bretagne Atlantique Prosper Chubert

Vannes, France

Location

Städtisches Klinikum St.Georg

Leipzig, Saxony, 04129, Germany

Location

Zentralklinik Bad Berka GmbH

Bad Berka, Germany

Location

HDZ Bad Oeynhausen

Bad Oeynhausen, 32545, Germany

Location

Maria Heimsuchung - Carita-Klinik Pankow

Berlin, 13187, Germany

Location

Städtisches Klinikum Brandenburg GmbH

Brandenburg, Germany

Location

Krankenhaus Buchholz und Winsen AöR

Buchholz, Germany

Location

Universitätsklinikum Erlangen

Erlangen, Germany

Location

Universitätsklinikum Giessen und Marburg

Giessen, 35392, Germany

Location

KMG Klinikum Güstrow

Güstrow, Germany

Location

Klinikum der Universität Jena

Jena, 07743, Germany

Location

Bonifatius Hospital Lingen gGmbH

Lingen, Germany

Location

Universitätsklinikum Schleswig-Holstein (UKSH) - Campus Lübeck

Lübeck, Germany

Location

Carl-von-Basedow-Klinikum Saalekreis GmbH

Merseburg, Germany

Location

Johannes Wesling Klinikum Minden

Minden, Germany

Location

Klinikum der LMU / Campus Großhadern

München, 81377, Germany

Location

Universitätsklinikum Münster

Münster, Germany

Location

Städtische Kliniken Neuss -Lukaskrankenhaus- GmbH

Neuss, Germany

Location

Schüchtermann Klinik, Herzzentrum Osnabrück-Bad Rothenfelde

Rothenfelde, Germany

Location

Universitätsklinikum Würzburg

Würzburg, Germany

Location

State Hospital of Cardiology

Balatonfüred, Hungary

Location

Gottsegen György Országos Kardiológiai Intézet

Budapest, Hungary

Location

Semmelweis Medical University

Budapest, Hungary

Location

The University of Pécs

Pécs, Hungary

Location

Assuta Medical Center

Ashdod, Israel

Location

Ben-Gurion University of the Negev

Beersheba, 84101, Israel

Location

Wolfson Medical Center

Holon, Israel

Location

Shaare Zedek Medical Center

Jerusalem, Israel

Location

Meir Medical Center

Kfar Saba, Israel

Location

Rabin Medical Center

Petah Tikva, 49100, Israel

Location

Kaplan Medical Center

Rehovot, Israel

Location

Chaim Sheba Medical Center

Tel Litwinsky, 52621, Israel

Location

Shamir Medical Center

Ẕerifin, 70300, Israel

Location

Ospedale San Raffaele

Milan, Italy

Location

Policlinico Casilino

Roma, Italy

Location

Kokura Memorial Hospital

Fukuoka, Japan

Location

Hiroshima Prefectural Hospital

Hiroshima, Japan

Location

Tokai University Hospital

Kanagawa, Japan

Location

Kitasato University Hospital

Sagamihara, Japan

Location

Saitama Medical University International Medical Center

Saitama, Japan

Location

Juntendo University Hospital

Tokyo, Japan

Location

Fujita Health University Hospital

Toyoake, Japan

Location

Pauls Stradins Clinical University Hospital

Riga, Latvia

Location

Medical University of Lodz

Lodz, Poland

Location

Szpital Kliniczny Przemienienia Pańskiego

Poznan, Poland

Location

The National Cardiology Institute of Stefan Cardinal Wyszynski - National Research Institute

Warsaw, Poland

Location

Hospital de Santa Cruz

Carnaxide, Portugal

Location

Hospital Espirito Santo de Evora

Evora, Portugal

Location

Hospital de Santa Maria

Lisbon, Portugal

Location

Hospital de Santo António

Porto, Portugal

Location

Changi General Hospital

Singapore, Singapore

Location

SÚSCCH

Banská Bystrica, Slovakia

Location

NÚSCH Bratislava a.s.

Bratislava, Slovakia

Location

East-Slovak Cardiology Institute (VUSCH)

Košice, Slovakia

Location

Mediclinic Panorama Hospital

Cape Town, South Africa

Location

Mediclinic Pietermaritzburg

Pietermaritzburg, South Africa

Location

Mediclinic Midstream

Pretoria, South Africa

Location

Unitas Hospital

Pretoria, South Africa

Location

Gateway Private Hospital

Umhlanga, South Africa

Location

Life Westville

Westville, South Africa

Location

Hospital General Universitario de Alicante

Alicante, Spain

Location

Centro Médico Teknon

Barcelona, 08022, Spain

Location

Hospital Universitario de Bellvitge

Barcelona, Spain

Location

Hospital Universitario de Burgos

Burgos, Spain

Location

Hospital Universitario Donostia

Donostia / San Sebastian, Spain

Location

Hospital Universitario 12 de Octubre

Madrid, Spain

Location

Hospital Universitario Virgen de la Victoria

Málaga, Spain

Location

Hospital General Universitario de Valencia

Valencia, Spain

Location

Hospital Universitario La Fé

Valencia, Spain

Location

Hospital Álvaro Cunqueiro

Vigo, Spain

Location

Universitätsspital Zürich

Zurich, Switzerland

Location

Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan

Location

Far Eastern Memorial Hospital

New Taipei City, Taiwan

Location

St. Peter's Hospital

Chertsey, United Kingdom

Location

Russells Hall Hospital

Dudley, United Kingdom

Location

Kettering General Hospital

Kettering, United Kingdom

Location

MeSH Terms

Conditions

Heart Failure

Interventions

Cardiac Resynchronization Therapy

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Cardiac Pacing, ArtificialElectric Stimulation TherapyTherapeutics

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2017

First Posted

December 8, 2017

Study Start

May 14, 2018

Primary Completion

September 22, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

No individual participant data in planned to be shared with other researchers

Locations